Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > Advisory Committee Outcomes
View:
Post by givmeabrake on Sep 10, 2015 7:26pm

Advisory Committee Outcomes

Here's an interesting report

Search this string in Google then open PDF

www.mckinsey.com/~/.../fda_advisory_committee_outcomes.ashx
Comment by simouuun on Sep 11, 2015 3:37am
Out of 49 drugs recommended by Adcom, 43 were approved by FDA = 87.75%
Comment by 13PunterDog on Sep 11, 2015 10:26am
With only two adverse reactions to treatment as I recall , one with a urinary tract infection which anyone can get, they will send this through pretty quick too. JMHO. Safety is paramount and with BCG shortage / uncertain supply / toxicity = MCNA slam dunk. Advisory committee meets late November , 6-8 weeks after that expect approval, again JMHO. Buy as much as you can in $.40's , will be ...more  
Comment by winx08 on Sep 11, 2015 2:08pm
@13PD, are the advisory commitee dates already known or is it a estimeated guess ? Will there be a special reporter (or how do they call it) who will write a report before de advisory comm ? Just followed your suggesting regarding buying :-) Reagrding AC´s .... Been on a bumpy ride in the past with CHTP. If i recall correctly, the first report was quite negative, AC vote 7-4 in favor and ...more  
Comment by 13PunterDog on Sep 12, 2015 11:47am
Winx: An estimated guess as it's halfway through our 6 month period. The FDA website has the Oncologic Advisory Committee meeting Nov 19-20. I think they meet 3-4 times a year ish , so the next meeting would be about late Jan - Feb '16 , cutting it close for Feb 27. The FDA usually follows it's recommendation , however , it is NOT binding. So don't anyone get their panties in a ...more  
Comment by DryBones on Sep 12, 2015 2:42pm
Punter,  whiile the FDA can ignore an Advisory Committee rejection, I have not seen it happen. The Advisory Committe are experts in their field. Only the heavy hitters, the big pharma, could mount a campaign to sidestep their recommendation. If the AdComm is positive, however, the FDA could still say no. I'm not worried about a no event too much, even though I think it is very ...more  
Comment by RetailRube on Sep 13, 2015 3:02pm
PD, might the Advisory Committee include any of the same people who participated in the panel of the FDA/AUA symposium on bladder cancer a couple of years ago?  After reading the transcript, I got a sense of how these people were thinking.
Comment by 13PunterDog on Sep 13, 2015 7:39pm
RR: No chance? Maybe one.Here is link to Oncologic drugs advisory committee and rosters throughout this year. https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/ucm426351.htm They have rosters for July 9'15 and Jan7'15 meetings. About half attended both meetings .Here is how the committee is made up , we should just send Dr Morales ...more  
Comment by Jasl on Sep 11, 2015 8:54am
Nice find givemeabrake very detailed report. Must have cost a few bucks. Looks like FDA human as well. Following the herd. Thanks for find.  Cheers JASL
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities